EQS-News

aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024

EQS-News: aap Implantate AG / Key word(s): Quarter Results/Development of Sales aap closes Q1 2024 with sales growth of 5.6% and positive developments at all operating levels and makes a strong start to Q2 2024 22.04.2024 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Sales increase by 5.6% compared to the same quarter of the previous year Major order and parts of Q1 sales form strong basis for growth in Q2 Human clinical trial of the innovative antibacterial implant technology is progressing positively and opens up the possibility of an earlier conclusion

aap Implantate AG ("aap" or "Company") continued its good start into the new year. The regions LATAM and APAC contributed significantly to growth.

 

Q1/2024 – Sales

Sales in TEUR	Q1/2024	Q1/2023	Change
EMEA (= Europe, Middle East, Africa)	1,456	1,533	-5.0 %
North America	731	897	-18.5 %
LATAM (= Latin America)	788	481	+63.8 %
APAC (= Asia-Pacific)	149	46	>+100 %
Sales	3,124	2,957	+5.6 %